Fatima Ezzahra Elamrani

Fatima Ezzahra Elamrani

Auto-generated profile, based on publicly available information

Fatima Ezzahra Elamrani

Cadi Ayyad University, Morocco

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2025
Verified
Book Chapter
Closed access
SMSaloua Mabsor-Zgandaoui
Saloua Mabsor-Zgandaoui
KRKhawla Rachmoune
Khawla Rachmoune
IAIlham Aftais
Ilham Aftais
FEFatima Ezzahra Elamrani
Fatima Ezzahra Elamrani
IAImade Amradi
Imade Amradi
AMAbdelhalim Mesfioui
Abdelhalim Mesfioui
Biomedical polymers have played a transformative role in modern medicine, driving innovation in drug delivery, tissue engineering and medical devices. These materials are classified as natural or synthetic and possess unique properties such as biocompatibility, biodegradability and mechanical versatility. Natural polymers support cellular functions and tissue regeneration, while synthetic polymers allow precise control of degradation rates and mechanical properties. Polymers have facilitated the controlled delivery of drugs through polymer-drug conjugates and stimulant systems, enabling targeted and sustained release. However, challenges such as toxicity, immune responses and regulatory hurdles remain. By exploring their applications, challenges and future prospects, this chapter has shed light on the essential role of biomedical polymers in advancing personalized medicine, regenerative therapies and smart medical devices.

26 September 2025
Verified
Book Chapter
Closed access
YHYoussef Ait Hamdan
Youssef Ait Hamdan
IAImade Armadi
Imade Armadi
KRKhawla Rachmoune
Khawla Rachmoune
FEFatima Ezzahra Elamrani
Fatima Ezzahra Elamrani
MMMaryem Mekouar
Maryem Mekouar
MRMohammed Rhazi
Mohammed Rhazi
Chitosan and its derivatives have garnered increasing interest in oncology due to their unique properties, such as biocompatibility, bioactivity and their ability to interact with molecules. These characteristics make them promising candidates for the development of novel anticancer therapies. Chitosan can be employed as drug delivery systems, enhancing the availability and targeted release of therapeutic agents into cancer cells. Additionally, they have demonstrated the ability to inhibit cell proliferation, induce apoptosis, and modulate immune responses, positioning them as multifunctional tools in the fight against cancer. Recent research has focused on the development of chitosan-based nanoparticles for targeted drug delivery in chemotherapy, reducing side effects on healthy cells. Furthermore, Chitosan systems have been used to deliver siRNA and other therapeutic molecules, inhibiting tumor growth at the genetic level. These advancements highlight chitosan's potential in developing more effective and less toxic cancer treatments.

2 July 2025
Verified
Book Chapter
Closed access
FEFatima Ezzahra Elamrani
Fatima Ezzahra Elamrani
SLSouad Loqman
Souad Loqman
ABAnass Belbachir
Anass Belbachir
The exposome concept has complemented the genome by opening new areas for cancer research. The in vitro models used in this context are fundamental for unraveling the molecular and cellular effects of carcinogenic agents in a controlled environment. Moreover, these models offer a new possibility for investigating the key mechanisms of tumor initiation and progression, bridging the gap between epidemiological data and mechanistic studies. In the same way, integrating recent technologies such as multiomics (genomics, transcriptomics, proteomics, metabolomics, etc.) expands the horizon for a deep understanding of cellular responses to carcinogenic exposures. This chapter reviews recent cutting-edge advances in using experimentation models to study the carcinogenic exposome. It emphasizes their role in understanding carcinogenesis pathways, focusing on the most up-to-date technologies.

26 September 2025
Verified
Book Chapter
Closed access
YHYoussef Ait Hamdan
Youssef Ait Hamdan
IAImade Armadi
Imade Armadi
SMSaloua Mabsor-Zgandaoui
Saloua Mabsor-Zgandaoui
FEFatima Ezzahra Elamrani
Fatima Ezzahra Elamrani
KRKhawla Rachmoune
Khawla Rachmoune
MRMohammed Rhazi
Mohammed Rhazi
Osteoporosis is a common degenerative disease in postmenopausal women, characterized by a loss of bone density and skeletal fragility, increasing fracture risk. This chapter examines the use of chitosan, a natural biopolymer derived from chitin, as a therapeutic agent in osteoporosis treatment. Chitosan's unique properties, such as biocompatibility, biodegradability, and the ability to form three-dimensional structures, make it a promising candidate for bone therapies. The chapter also analyzes chemical and functional modifications to chitosan that enhance its bioactive effects and drug delivery capabilities, offering promising perspectives for non-hormonal osteoporosis treatments.